Transitional polytherapy, liver enzymes, and valproic acid hepatotoxicity.
D000927:Anticonvulsants / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D008099:Liver / Q000201:enzymology*; D014635:Valproic Acid / Q000009:adverse effects*
D000927:Anticonvulsants; D014635:Valproic Acid